Nasdaq Stock News

NEW YORK, Dec. 10, 2021 (GLOBE NEWSWIRE) -- Nasdaq (Nasdaq: NDAQ) today announced the results of the annual reconstitution of the Nasdaq Biotechnology Index (Nasdaq: NBI), which will become effective prior to market open on Monday, December 20, 2021.

NEW YORK, Dec. 10, 2021 (GLOBE NEWSWIRE) -- Nasdaq (Nasdaq: NDAQ) today announced the results of the annual reconstitution of the Nasdaq-100 Index ® (Nasdaq: NDX), which will become effective prior to market open on Monday, December 20, 2021.

In the latest trading session, Spotify (SPOT) closed at $233.26, marking a -0.07% move from the previous day. This change lagged the S&P 500s 0.96% gain on the day. At the same time, the Dow added 0.61%, and the tech-heavy Nasdaq lost 0.04%. Prior to todays trading, shares of the music-streaming service operator had lost [] The post Spotify (SPOT) Stock Sinks As Market Gains: What You Should Know appeared first on UK Stocks, Forex, Commodities, Crypto, Live Market News- Daily Forex News .

NEW YORK, Dec. 10, 2021 /PRNewswire/ -- LivePerson, Inc. (Nasdaq: LPSN) is providing confirmatory notice, in compliance with the requirements of Nasdaq Listing Rule 5635(c)(4), of recent grants of equity-based incentive awards that LivePerson made under its

NEW YORK, Dec. 10, 2021 /PRNewswire/ -- BurTech Acquisition Corp (the "Company") announced today that it priced its initial public offering of 25,000,000 units at $10.00 per unit. The units will be listed on the Nasdaq Global Market ("Nasdaq") and are expected to begin trading Monday,

BEIJING , Dec. 11, 2021 /PRNewswire/ -- Pintec Technology Holdings Limited (Nasdaq: PT) ("PINTEC" or the "Company"), a leading independent technology platform enabling financial services in China , today announced that it received notification from NASDAQ Listing Qualifications ("NASDAQ") on December 9, 2019 that it is not in compliance with the minimum bid price requirement set forth in Listing Rules for continued listing on the NASDAQ Stock Exchange as the closing price of the Company''s ADSs have been less than US$1 over a consecutive 30-trading-day period. In accordance with Listing Rule 5810(c)(3)(A), the Company has a period of 180 calendar days from the date of notification, being until June 6, 2022, to regain compliance with the minimum bid price. In order to regain compliance, the Company''s ADSs must have a closing bid price of at least US$1 for a minimum of 10 consecutive trading days. In the event that the Company does not regain compliance during the first notice period of 180 calendar days, or by June 6, 2022, the Company may be eligible for additional time to regain compliance or may face delisting from the exchange.

This past summer, Mind Medicine (MindMed) Inc (NASDAQ: MNMD ), a medicine biotech in the psychedelics sector, announced the departure of co-founder and CEO J.R. Rahn . In learning more about the changes that have taken place since, Benzinga spoke with Robert Barrow , the firms chief development officer, who took the role of CEO after Rahn. Context: In light of the stagnation of traditional mental health care infrastructure, MindMed launched to discover, develop and deploy treatments that address and avoid the adverse effects of abuse and dependence. During his tenure, Rahn introduced a broader audience to ongoing research and resource gaps around medicinal psychedelics. He raised $200 million, honed relationships with leading research groups and listed MindMed on Nasdaq Inc (NASDAQ: NDAQ ), bolstering innovation and allowing both retail and institutional investors a chance to participate in the new age of medicine. However, Rahn felt it was time to step away. He told Benzinga that MindMed was a brand that needed to focus more on drug development. Every company needs a different leader for a different time, he had said. I believe I was the right leader, at the right time and this transition is just a natural progression. About Barrow: My background is in the pharmaceutical industry where I was, for about 10 years, the chief operating officer of a clinical-stage drug development company, Barrow said of

Omi-Gone? Stocks Soar As Scariant & CPI Send Bonds, Bitcoin, & The Buck Lower On The Week It has been two weeks since the deadly (no one has died anywhere in the world) new COVID variant - Omicron - and only The Dow has managed to shrug off the constant fearmongering and panicky policy-making to ''slow the spread'' of this "mild" virus Small Caps are notably ugly since Omicron was unleashed on the world. But this week saw the S&P rip to its best week since February as Goldman''s melt-up appears to have come true ... Today was dominated by CPI - which printed at its hottest in 40 years but was modestly below the whisper number - and that sent yields lower (especially the short-end) and implicitly Nasdaq and S&P (growth) higher as Small Caps (value) lower. Everything went vertical in the last couple of minutes... just like last Friday... A record close for the S&P 500 This week''s gains in stocks were ignited by a major short-squeeze in the first half of the week, but that faded as the week wore on...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Most of Buzzfeed''s private equity funders chose to cash out when they could. The digital media company raised most of its money with convertible stock, which is rapidly falling in value. The post Buzzfeed Lands on NASDAQ With a Thud appeared first on InvestorPlace . More From InvestorPlace Stock Prodigy Who Found NIO at $2 Says Buy THIS Now Man Who Called Black Monday: Prepare Now. #1 EV Stock Still Flying Under the Radar Interested in Crypto? Read This First

Two new cannabis-centric stocks debuted on Nasdaq this week

Copenhagen, December 10, 2021 - Nasdaq (Nasdaq: NDAQ) announced today the results of the semi-annual review of the OMX Copenhagen 25 Index (Nasdaq Copenhagen: OMXC25) which will become effective at

The ad-tech player recently uplisted to the Nasdaq and has interesting growth prospects Related Stocks: MOBQ , AMZN , XAMS:PHIA , TSE:4578 ,

BioLineRx (NASDAQ:BLRX) issued its quarterly earnings results on Wednesday. The biotechnology company reported ($0.15) EPS for the quarter, topping analysts consensus estimates of ($0.16) by $0.01, Fidelity Earnings reports. Shares of NASDAQ BLRX opened at $2.27 on Friday. The business has a fifty day simple moving average of $2.72 and a 200 day simple moving []

Electric carmaker Lucid Motors (LCID) went public on the Nasdaq in July, growing quickly to more than $90 billion in market capitalization (through mid-last month)….